Tag: Japan

  • Health News Roundup: Japan marks record 415 COVID-19 deaths -health ministry; U.S. to impose mandatory COVID-19 tests for travelers from China and more

    Health News Roundup: Japan marks record 415 COVID-19 deaths -health ministry; U.S. to impose mandatory COVID-19 tests for travelers from China and more

    Subsequent is a summary of recent health and fitness information briefs.

    &#13

    Japan marks document 415 COVID-19 deaths -wellbeing ministry

    &#13

    Japan on Wednesday recorded 415 COVID-19 deaths, the highest-ever depend for a solitary working day, well being ministry details confirmed. The state counted 216,219 newly confirmed coronavirus instances on Wednesday, up 4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} from a 7 days earlier, the data also confirmed, approaching the report superior of some 260,000 a working day in August.

    &#13

    U.S. to impose necessary COVID-19 assessments for travelers from China

    &#13

    The United States will impose required COVID-19 tests on tourists from China, U.S. wellbeing officials reported on Wednesday, becoming a member of India, Italy, Japan and Taiwan in getting new steps just after Beijing’s selection to elevate stringent zero-COVID guidelines. The officers told reporters that starting on Jan. 5, all air travellers 2 several years outdated and more mature will require a damaging result from a check no a lot more than two times before departure from China, Hong Kong or Macao.

    &#13

    Australia states no transform to procedures concerning travellers from China

    &#13

    Australia is building no modify to its regulations all around letting travellers from China into the country, even with measures by some international locations to involve obligatory COVID-19 tests, Australian Primary Minister Anthony Albanese reported on Thursday. “We will just take the proper assistance from the wellness professionals,” Albanese informed the Australian Broadcasting Corp (ABC).

    &#13

    China’s large countryside in hurry to bolster COVID defences

    &#13

    China’s sprawling and thinly resourced countryside is racing to beef up healthcare services before hundreds of hundreds of thousands of manufacturing unit employees return to their people for the Lunar New 12 months vacation next thirty day period from metropolitan areas where COVID-19 is surging. Getting imposed the world’s strictest COVID regime of lockdowns and relentless tests for a few a long time, China reversed class this month towards dwelling with the virus, leaving its fragile health system confused.

    &#13

    Hong Kong asks Japan to fall airport restrictions with 60,000 travellers impacted

    &#13

    Hong Kong’s governing administration has questioned Japan to withdraw a COVID-19 restriction that needs passenger flights from the financial hub to land at only four selected Japanese airports, indicating the selection will effects all-around 60,000 passengers. Japan, which is a best vacation place for Hong Kong people today, explained it would restrict flights from Hong Kong, Macau and mainland China to Tokyo’s two airports, additionally Osaka and Nagoya from Friday. The selection comes in the course of a peak travel season and forward of the Lunar New Calendar year holiday getaway which begins Jan. 22.

    &#13

    Hong Kong scraps most COVID guidelines, though masks continue to mandated

    &#13

    Hong Kong will cancel its stringent COVID-19 procedures from Thursday, metropolis chief John Lee stated, meaning that arrivals will no longer will need to do necessary PCR tests while the city’s vaccine pass would also be scrapped. All measures would be cancelled on Thursday, apart from the sporting of masks which even now remains obligatory, Lee explained to a media briefing on Wednesday.

    &#13

    Novartis to pay out $245 million to conclusion antitrust scenarios over Exforge drug generics

    &#13

    Novartis AG stated on Wednesday it will pay out $245 million to end antitrust litigation accusing the Swiss drugmaker of seeking to hold off the start in the United States of generic variations of its Exforge hypertension drug. The settlements with so-called immediate purchasers, indirect purchasers and vendors demand approval by a federal judge in Manhattan, and will resolve all outstanding statements against the firm over the make a difference, Novartis mentioned.

    &#13

    Factbox-COVID principles for travellers from China rolled out all over the earth

    &#13

    A number of locations all-around the entire world have imposed curbs on travellers from China amid a COVID-19 surge following Beijing peaceful demanding “zero-COVID” measures. They cite a absence of information from China on variants and are involved about a wave of bacterial infections. China has turned down criticism of its statistics and mentioned it expects upcoming mutations to be possibly extra virulent but much less significant.

    &#13

    U.S. Fda approves TG Therapeutics’ a number of sclerosis drug shares surge

    &#13

    TG Therapeutics Inc reported on Wednesday that the U.S. well being regulator had accredited its monoclonal antibody for treating individuals with relapsing forms of numerous sclerosis, sending its shares up 47{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} in afternoon trade. The acceptance by the U.S. Food items and Drug Administration (Food and drug administration) widens the range of this kind of medicine offered for managing the condition to a few and may assistance soften the blow to the company’s funds from the withdrawal of its lymphatic most cancers drug earlier this yr.

    &#13

    Uzbekistan states 18 young children die soon after consuming India-made syrup

    &#13

    Uzbekistan’s overall health ministry has stated at least 18 kids have died immediately after consuming a medicinal syrup manufactured by Indian drugmaker Marion Biotech Pvt Ltd. The ministry claimed 18 out of 21 kids who took the Doc-1 Max syrup when suffering from an acute respiratory disorder died following consuming it. It is marketed on the firm’s web site as a cure for cold and flu signs or symptoms.

    (With inputs from companies.)

  • Medical Marijuana, Inc. Celebrates Largest Revenue Month of 2022 in April, Japan Division Achieves Best Revenue Month in History of the Company

    Medical Marijuana, Inc. Celebrates Largest Revenue Month of 2022 in April, Japan Division Achieves Best Revenue Month in History of the Company

    Medical Marijuana, Inc.

    Medical Marijuana, Inc.

    SAN DIEGO, CA, Might 12, 2022 (Globe NEWSWIRE) — through NewMediaWireHealthcare Marijuana, Inc. (OTC: MJNA) (the “Company”), the 1st-at any time publicly traded hashish company in the United States that released the world’s first-ever cannabis-derived nutraceutical merchandise, brands, and provide chain, introduced now that in April, the Company has achieved its biggest earnings thirty day period of 2022 and its subsidiary Kannaway® has achieved its greatest revenue thirty day period in the company’s record in its Japan division.

    Major analyst company Study and Markets predicts that the world-wide cannabidiol (CBD) oil sector is envisioned to attain $5.3 billion by 2025 with Asia-Pacific as a single of the fastest-expanding areas. In fact, Japan’s CBD market is projected to turn into the 2nd-most significant CBD current market in Asia.

    “Medical Cannabis, Inc. carries on to build on its global footprint in 2022 and we are very pleased to be the chief in creating cost-free obtain to cannabis-based items all around the planet,” reported Kannaway® CEO Blake Schroeder. “Specifically, the Asia-Pacific has been a main progress area for our Business and was a significant contributor to our development in April. We are connecting with new people in Japan everyday and anticipate this development to continue.”

    About Health-related Marijuana, Inc.

    We are a firm of firsts®. Professional medical Cannabis, Inc. (MJNA) is a cannabis corporation with 3 distinctive business models in the non-psychoactive cannabinoid space: a international portfolio of cannabinoid-based nutraceutical manufacturers led by Kannaway® and HempMeds® a pioneer in sourcing the best-high-quality lawful non-psychoactive hashish solutions derived from industrial hemp and a cannabinoid-primarily based scientific analysis and botanical drug development sector led by its pharmaceutical financial investment providers and associates including AXIM® Biotechnologies, Inc. and Neuropathix. Clinical Cannabis, Inc. was named a top rated CBD producer by CNBC. Health care Marijuana, Inc. was also the first company to acquire historic import permits for CBD products and solutions from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the enhancement of global marketplaces. The firm’s flagship products True Scientific Hemp Oil has been made use of in a number of successful medical reports throughout Mexico and Brazil to recognize its basic safety and efficacy.

    Clinical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by traveling to www.medicalmarijuanainc.com. To see Health care Marijuana, Inc.’s corporate video clip, click right here.

    Forward-Searching DISCLAIMER

    This push launch might comprise sure forward-seeking statements and data, as described inside the this means of Section 27A of the Securities Act of 1933 and Segment 21E of the Securities Trade Act of 1934, and is subject matter to the Secure Harbor produced by all those sections. This material includes statements about predicted long run events and/or economical outcomes that are forward-hunting in nature and subject to threats and uncertainties. These forward-searching statements by definition include dangers, uncertainties and other aspects, which may possibly induce the precise outcomes, performance or achievements of Clinical Marijuana, Inc. to be materially diverse from the statements made herein.

    Food AND DRUG ADMINISTRATION (Fda) DISCLOSURE

    These statements have not been evaluated by the Food stuff and Drug Administration. This item is not meant to diagnose, handle, cure, or avoid any illness.

    Legal DISCLOSURE

    Medical Cannabis, Inc. does not market or distribute any solutions that are in violation of the United States Controlled Substances Act.

    Speak to:
    Public Relations Contact:
    Kathryn Brown
    Account Director
    CMW Media
    P. 858-264-6600
    [email protected]
    www.cmwmedia.com

    Investor Relations Call:
    P. (858) 283-4016
    [email protected]